Related Experiment Videos
E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity
T A Walker1, B A Wilson, A M Lewis
1Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
Abstract:
The manner in which oncogenes influence tumorigenicity beyond their ability to immortalize cells is uncertain. We tested the hypothesis that, in addition to subverting cellular growth controls, oncogenes can actively determine tumor-inducing capacity by affecting neoplastic cell susceptibility to destruction by the host cellular immune response. The adenovirus type 5 E1A oncogene, which induces susceptibility to lysis by natural killer cells and encodes epitopes recognized by cytotoxic T lymphocytes, was transfected into highly tumorigenic sarcoma cells. E1A expression in these sarcoma cells eliminated their tumorigenicity in recipients with natural killer cell activity that was competent to lyse these E1A-positive targets. Thymus-dependent responses were not required for tumor rejection. These results indicate that oncogene-regulated cellular pathways that affect neoplastic cell susceptibility to natural killer cell lytic mechanisms may influence tumor development in the immunocompetent host.
Insights
Oncogenes can impact tumor development by making cancer cells vulnerable to natural killer cells. This study shows that E1A oncogene expression in sarcoma cells reduced their ability to form tumors in mice.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Oncogenes are known to promote cell growth and immortalization.
- The precise mechanisms by which oncogenes influence tumorigenicity beyond cell immortalization remain unclear.
- It is hypothesized that oncogenes may actively modulate tumor development by affecting cancer cell interactions with the host immune system.
Purpose of the Study:
- To investigate if oncogenes can actively determine tumor-inducing capacity by altering cancer cell susceptibility to immune destruction.
- To test the role of the adenovirus type 5 E1A oncogene in modulating neoplastic cell vulnerability to the host cellular immune response.
Main Methods:
- Transfection of the adenovirus type 5 E1A oncogene into highly tumorigenic sarcoma cells.
- Assessment of tumor formation in recipient mice with competent natural killer (NK) cell activity.
- Evaluation of the role of thymus-dependent immune responses in tumor rejection.
Main Results:
- E1A oncogene expression in sarcoma cells led to their elimination by NK cells.
- Sarcoma cells expressing E1A demonstrated significantly reduced tumorigenicity in immunocompetent recipients.
- Tumor rejection was observed independently of thymus-dependent (T-cell mediated) immune responses.
Conclusions:
- Oncogene-regulated pathways can influence cancer cell susceptibility to NK cell-mediated lysis.
- Modulating cancer cell vulnerability to NK cell destruction is a potential mechanism affecting tumor development in immunocompetent hosts.
- The E1A oncogene's ability to enhance susceptibility to NK cell lysis plays a critical role in preventing tumor formation.